Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study (Q38468641)
Jump to navigation
Jump to search
scientific article published on 30 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study |
scientific article published on 30 June 2012 |
Statements
1 reference
Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study (English)
1 reference
Roman S Lorenc
1 reference
Steven Boonen
1 reference
Dietrich Wenderoth
1 reference
Karen J Stoner
1 reference
Rachelle Eusebio
1 reference
30 June 2012
1 reference
1 reference
51
1 reference
3
1 reference
383-388
1 reference
Identifiers
1 reference
1 reference